These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19414859)

  • 21. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
    Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
    Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
    Sheehan JP; Tollefsen DM; Sadler JE
    J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis of the cofactor- and substrate-assisted activation of human coagulation factor IXa.
    Zögg T; Brandstetter H
    Structure; 2009 Dec; 17(12):1669-1678. PubMed ID: 20004170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation.
    Soeda T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2011 Nov; 106(5):893-900. PubMed ID: 21947241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Native Fucosylated Glycosaminoglycan, Its Depolymerized Derivatives on Intrinsic Factor Xase, Coagulation, Thrombosis, and Hemorrhagic Risk.
    Zhou L; Gao N; Sun H; Xiao C; Yang L; Lin L; Yin R; Li Z; Zhang H; Ji X; Zhao J
    Thromb Haemost; 2020 Apr; 120(4):607-619. PubMed ID: 32289860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulant activities of a monoclonal antibody that binds to exosite II of thrombin.
    Lian F; He L; Colwell NS; Lollar P; Tollefsen DM
    Biochemistry; 2001 Jul; 40(29):8508-13. PubMed ID: 11456488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
    van 't Veer C; Mann KG
    J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
    Qureshi SH; Yang L; Rezaie AR
    Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11.
    Ahmad SS; Rawala-Sheikh R; Cheung WF; Jameson BA; Stafford DW; Walsh PN
    Biochemistry; 1994 Oct; 33(40):12048-55. PubMed ID: 7918424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size.
    Li J; Li S; Yan L; Ding T; Linhardt RJ; Yu Y; Liu X; Liu D; Ye X; Chen S
    Eur J Med Chem; 2017 Oct; 139():191-200. PubMed ID: 28800457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator.
    Barrow RT; Parker ET; Krishnaswamy S; Lollar P
    J Biol Chem; 1994 Oct; 269(43):26796-800. PubMed ID: 7929416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic interactions of factor IXa with human factor VIII and factor VIIIa.
    Lamphear BJ; Fay PJ
    Blood; 1992 Dec; 80(12):3120-6. PubMed ID: 1467518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation mechanisms of coagulation factor IX.
    Zögg T; Brandstetter H
    Biol Chem; 2009; 390(5-6):391-400. PubMed ID: 19361276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of factor VIII and mechanisms of cofactor action.
    Fay PJ
    Blood Rev; 2004 Mar; 18(1):1-15. PubMed ID: 14684146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Glu113Ala mutation within a factor VIII Ca2+-binding site enhances cofactor interactions in factor Xase.
    Wakabayashi H; Su YC; Ahmad SS; Walsh PN; Fay PJ
    Biochemistry; 2005 Aug; 44(30):10298-304. PubMed ID: 16042406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
    Myles T; Church FC; Whinna HC; Monard D; Stone SR
    J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
    Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
    Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.